Moreover, survival analysis using ovarian cancer microarray datasets (GSE9891 and GSE17260) indicated a significant association between high CCDC69 expression and better patient survival in the PrognoScan database [30–32] (Fig. 1 b and c,p = 0.033 and p = 0.044, respectively). Here, CCDC69 is linked to ovarian carcinoma.